v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2023 $ 541,518 $ 4 $ 10,827,378 $ (10,280,915) $ (4,949)
Beginning balance (in shares) at Dec. 31, 2023   399,806      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options 1,924   1,924    
Issuance of common stock upon exercise of stock options (in shares)   257      
Issuance of common stock upon settlement of restricted stock units (in shares)   6,280      
Shares withheld related to net share settlement (1,463)   (1,463)    
Shares withheld related to net share settlement (in shares)   (82)      
Repurchase and retirement of common stock (50,000)   (50,000)    
Repurchase and retirement of common stock (in shares)   (3,143)      
Purchase of capped call (47,886)   (47,886)    
Stock-based compensation 80,098   80,098    
Other comprehensive loss (1,324)        
Net income (loss) (31,535)     (31,535)  
Ending balance at Mar. 31, 2024 491,332 $ 4 10,810,051 (10,312,450) (6,273)
Ending balance (in shares) at Mar. 31, 2024   403,118      
Beginning balance at Dec. 31, 2024 767,016 $ 4 11,035,246 (10,258,131) (10,103)
Beginning balance (in shares) at Dec. 31, 2024   418,005      
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon settlement of restricted stock units (in shares)   4,157      
Shares withheld related to net share settlement (24,294)   (24,294)    
Shares withheld related to net share settlement (in shares)   (1,814)      
Stock-based compensation 93,158   93,158    
Other comprehensive loss (332)       (332)
Net income (loss) 2,567     2,567  
Ending balance at Mar. 31, 2025 $ 838,115 $ 4 $ 11,104,110 $ (10,255,564) $ (10,435)
Ending balance (in shares) at Mar. 31, 2025   420,348